World-First Mobile CT to Be Developed for Regional Healthcare

February 13, 2025 11:33 AM AEDT | By Business Wire
 World-First Mobile CT to Be Developed for Regional Healthcare
Image source: Kalkine Media

ADELAIDE, Australia--(BUSINESS WIRE)--Australian X-ray technology company Micro-X will develop a world-first full-body mobile CT following the award of an up to US$16.4m (A$25m) development contract from the US Advanced Research Projects Agency for Health (ARPA-H).



The contract to develop a lightweight and portable full body CT comes under the US Government agency’s Platform Accelerating Rural Access to Distributed and Integrated Medical Care (PARADIGM) program. PARADIGM aims to address the current challenges in accessing rural health, by creating a scalable vehicle-based platform that provides advanced medical services out of hospital.

ARPA-H will fund the development of the medical device over five years, subject to ARPA-H option, through to FDA premarket submission (501k).

Using Micro-X's small but powerful Nano Electronic X-ray (NEX) Technology X-ray tubes, the company aims to deliver a full body CT weighing just 225 kilograms, compared to conventional CTs that weigh more than 2000 kilograms. This technology has previously been advanced through Micro-X development contracts awarded by the US Department of Homeland Security (DHS) and Australian Medical Research Future Fund (MRFF).

Conventional CT holds the largest share (approximately 30%) of the global medical imaging market and is the current medical imaging standard for a wide range of diagnoses including cardiac imaging, trauma diagnosis, cancer screening, and lung screening.

Micro-X Chief Executive Officer Kingsley Hall commented: “Micro-X continues to go beyond boundaries to challenge the constraints of legacy X-ray and deliver solutions that meet the needs of customers, users and patients.”

Micro-X’s CEO US and Chief Scientific Officer US Brian Gonzales said: “ARPA-H’s vision for the PARADIGM Program is closely aligned with Micro-X’s vision to create revolutionary X-ray imaging to better lives. We are extending hospital grade imaging beyond the boundaries of conventional hospitals to bring a vehicle mounted Full Body CT solution to rural communities."

Images available for publication: Click here

About Micro-X

Micro-X Limited is an ASX listed hi-tech company developing and commercializing a range of innovative products for global health and security markets, based on proprietary cold cathode, carbon nanotube (CNT) emitter technology. The electronic control emitters with this technology enables x-ray products with significant reduction in size, weight and power requirements, enabling greater mobility and ease of use. Micro-X has a fully vertically integrated design and production facility in Adelaide, Australia. A growing technical and commercial team based in Seattle is rapidly expanding Micro-X’s US business.

Micro-X’s product portfolio spans four, high margin, product applications in health and security. The first mobile digital radiology products are used for diagnostic imaging in global healthcare, military and veterinary applications. The US Department of Homeland Security has contracted Micro-X to design a next-generation Airport security checkpoint. A brain CT imager for pre-hospital stroke diagnosis in ambulances, is being developed with funding from the Australian Government’s Medical Research Future Fund. A full body CT is being developed with funding from US Government agency ARPA-H.
Contacts

Media contact: Head of Corporate Communications Rebecca Puddy, [email protected] +61 403 861 112.


Disclaimer

The content, including but not limited to any articles, news, quotes, information, data, text, reports, ratings, opinions, images, photos, graphics, graphs, charts, animations and video (Content) is a service of Kalkine Media Pty Ltd (“Kalkine Media, we or us”), ACN 629 651 672 and is available for personal and non-commercial use only. The principal purpose of the Content is to educate and inform. The Content does not contain or imply any recommendation or opinion intended to influence your financial decisions and must not be relied upon by you as such. Some of the Content on this website may be sponsored/non-sponsored, as applicable, but is NOT a solicitation or recommendation to buy, sell or hold the stocks of the company(s) or engage in any investment activity under discussion. Kalkine Media is neither licensed nor qualified to provide investment advice through this platform. Users should make their own enquiries about any investments and Kalkine Media strongly suggests the users to seek advice from a financial adviser, stockbroker or other professional (including taxation and legal advice), as necessary.
The content published on Kalkine Media also includes feeds sourced from third-party providers. Kalkine does not assert any ownership rights over the content provided by these third-party sources. The inclusion of such feeds on the Website is for informational purposes only. Kalkine does not guarantee the accuracy, completeness, or reliability of the content obtained from third-party feeds. Furthermore, Kalkine Media shall not be held liable for any errors, omissions, or inaccuracies in the content obtained from third-party feeds, nor for any damages or losses arising from the use of such content.
Kalkine Media hereby disclaims any and all the liabilities to any user for any direct, indirect, implied, punitive, special, incidental or other consequential damages arising from any use of the Content on this website, which is provided without warranties. The views expressed in the Content by the guests, if any, are their own and do not necessarily represent the views or opinions of Kalkine Media. Some of the images/music that may be used on this website are copyrighted to their respective owner(s). Kalkine Media does not claim ownership of any of the pictures displayed/music used on this website unless stated otherwise. The images/music that may be used on this website are taken from various sources on the internet, including paid subscriptions or are believed to be in public domain. We have made reasonable efforts to accredit the source wherever it was indicated as or found to be necessary.
This disclaimer is subject to change without notice. Users are advised to review this disclaimer periodically for any updates or modifications.


AU_advertise

Advertise your brand on Kalkine Media

Sponsored Articles


Investing Ideas

Previous Next
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.